Zevtera

CHMP Delays Decision to Approve Zevtera

Janssen-Cilag has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has decided to delay the European Commission decision process on Zevtera (ceftobiprole medocaril) pending completion of a …

Zevtera | 02 March 2009

• Janssen-Cilag
• CHMP
• Zevtera
• skin